Check out your Company Bowl for anonymous work chats.
Paige is excited to announce CE-IVD and UKCA marking for HER2Complete, an artificial intelligence (AI) software designed to identify patients with breast cancer whose tumors have expressions of human epidermal growth factor receptor 2 (HER2) protein. HER2Complete has been shown to potentially detect levels of HER2 expression in HER2-negative (IHC-0) and HER2-low (IHC1+/2+) H&E-stained tissue samples.
Paige Answers Call to Better Identify Breast Cancer Patients with Low Expression of HER2
Paige is honored to have worked alongside the ARTICULATE PRO study team. This includes patient representatives; Prostate Cancer UK, University of Oxford, Oxford University Hospitals NHS Foundation Trust, University of Glasgow and Queen Elizabeth Hospital NHS Trust on an important study assessing how patients view the use of digital pathology and AI during their diagnosis. The findings shed light on patients’ support for the use of new technologies in the diagnostic process, their concerns, and their interest to learn more about these developments.
The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters
Paige and Janssen collaborate to deploy the first of its kind, AI-powered, H&E-based biomarker test used to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds.
Paige Announces Collaboration to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
Through our newly formed partnership with Ultivue we will be able to unite two platform-agnostic technologies to provide robust biomarker detection capabilities and elevate how immuno-oncology research is done today.
Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige for AI-Powered Biomarker Imaging Solutions for Precision Medicine
Today we launched our latest product, Paige Breast Lymph Node, a clinical #AI application that helps pathologists detect if breast cancer has metastasized to the lymph nodes.
Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes
We are excited to announce our partnership with Flagship Biosciences, Inc. to expand access to immuno-oncology biomarker analysis. Flagship’s PD-L1 analysis tool, TissueInsight™ will be available directly in the FullFocus® platform to provide pathologists and oncologists quick and seamless access to biomarker testing results that will inform treatment planning.
Paige and Flagship Biosciences Announce Partnership to Expand Access to Immuno-Oncology Biomarker Analysis Tools
Paige and Mindpeak Announce Partnership to Expand Access to Industry-Leading AI Software for Breast Cancer. Paige, the global leader in AI-based diagnostic software in pathology, and Mindpeak, the European leader for AI-based software for image analysis in pathology have announced a distribution partnership, which will enable pathologists to use Mindpeak’s BreastIHC* within the Paige Platform. Mindpeak’s BreastIHC is an AI software that reliably and accurately detects, classifies and quantifies breast cancer cells. This partnership enhances the utility of the Paige Platform by providing real-time results for routine breast cancer immunohistochemistry (IHC) biomarkers.
Paige and Mindpeak Announce Partnership to Expand Access to Industry-Leading AI Software for Breast Cancer
Paige Announces New UK Study to Evaluate AI Tools That Determine Spread of Cancer Beyond Breast Tissue. The pathology leaders at Guy's and St Thomas' NHS Foundation Trust and King's College Hospital NHS Foundation Trust are using the power of Paige AI to further advance the methods and science to help patients receive the most accurate diagnoses and to make life-changing decisions on treatment.
AI technology investigated for breast cancer diagnosis - BRC
Inform Diagnostics Leverages the Power of Digital Pathology with the Launch of Paige FullFocus™ Viewer. Adoption of the new technology allows pathologists at Inform Diagnostics to use AI tools, streamline logistics, and achieve faster turnaround times of results.
Inform Diagnostics Leverages the Power of Digital Pathology with the Launch of Paige FullFocus™ Viewer.
2021 was a landmark year for Paige’s growth and evolution as we solidified our position as the global leader in AI-based diagnostic software in pathology. Read our end of year review!
2021 Year End Review
Copyright © 2008-2026. Indeed, Inc. "Glassdoor," "Worklife Pro," "Bowls," and logo are proprietary trademarks of Indeed, Inc.